Genexine, Inc.

Handok Inc.

Msd International Gmbh

Jung Won Woo

Tae Kyung Kim

Woo Ick Jang

Young Chul Sung

Jong Sup Park

Joan Yoon Ji Lee

Ji-Eun Cha

Young Joo Ahn

Jin Won Youn

Young-Joo Ahn

Hyou Young Rhim

Young_Joo Ahn

Joan Yoon Lee

A method for treating growth hormone deficiency, including administering a human growth hormone fusion protein (GX-H9). A method includes administering a pharmaceutical composition containing an hGH fusion protein (GX-H9) and a pharmaceutically acceptable carrier, wherein the fusion protein (GX-H9) is administered once a week at a dose of 0.4 to 1.6 mg per body weight kg of a pediatric patient, or administered once every two weeks at a dose of 0.8 to 3.2 mg per body weight kg of a pediatric patient.

Method for treating growth hormone deficiency employing hGH fusion protein

Provided are a method for administering a recombinant human growth hormone GX-H9 for treating growth hormone deficiency and a pharmaceutical composition containing a recombinant human growth hormone GX-H9 and a pharmaceutically acceptable carrier. The method includes administering recombinant human growth hormone GX-H9 once a week with a dosage of 0.1 to 0.3 mg per weight kg of a patient or twice-monthly with a dosage of 0.1 to 0.4 mg per weight kg of the patient.

Pharmaceutical composition comprising recombinant hGH for the treatment of growth hormone deficiency

A treatment of cervical tumor caused by human papillomavirus (HPV) infection is disclosed. Methods for improving cervical tumor treatment and methods for treating cervical tumor caused by HPV infection include administering a combination of a HPV-specific fusion protein and an immunomodulatory agent.

Method for treating cervical cancer

Growing community of inventors

Seoul, South Korea

Jung Won Woo